SCHEMBL5489648

SCHEMBL5489648

C(=C(c1ccccc1)c1nc2ccccc2[nH]1)c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 7/20 0.55
▸ NPC1 O15118 6/20 0.55
▸ RAB9A P51151 6/20 0.55
▸ SMN1; SMN2 Q16637 6/20 0.55
▸ NPSR1 Q6W5P4 4/20 0.55
▸ LMNA P02545 4/20 0.55
▸ ALDH1A1 P00352 4/20 0.55
▸ MEN1 O00255 3/20 0.55
▸ KMT2A Q03164 3/20 0.55
▸ HTT P42858 2/20 0.55
▸ POLB P06746 2/20 0.55
▸ CYP1A2 P05177 1/20 0.55
▸ CYP3A4 P08684 1/20 0.55
▸ CYP2C9 P11712 1/20 0.55
▸ CYP2C19 P33261 1/20 0.55
▸ GFER P55789 1/20 0.52
▸ KDM4E B2RXH2 6/20 0.52
▸ NTSR1 P30989 1/20 0.52
▸ AURKA O14965 1/20 0.50
▸ JAK2 O60674 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30999512 0.92 NPC1 (0.56) MAPTNPC1RAB9ASMN1; SMN2NPSR1
SCHEMBL12540590 0.87 FAAH (0.56) MAPTNPC1RAB9ASMN1; SMN2NPSR1
SCHEMBL12540588 0.87 FAAH (0.56) MAPTNPC1RAB9ASMN1; SMN2NPSR1
SCHEMBL28029757 0.80 NPC1 (0.51) MAPTNPC1RAB9ASMN1; SMN2NPSR1
SCHEMBL11174009 0.78 XDH (0.55) MAPTNPC1RAB9ASMN1; SMN2NPSR1
SCHEMBL11800918 0.77 AURKA (0.56) MAPTNPC1RAB9ASMN1; SMN2NPSR1
SCHEMBL10362585 0.76 AURKA (0.59) MAPTNPC1RAB9ASMN1; SMN2NPSR1
SCHEMBL27983608 0.76 MAPT (0.82) MAPTNPC1RAB9ASMN1; SMN2NPSR1
SCHEMBL11326909 0.75 FAAH (0.53) MAPTNPC1RAB9ASMN1; SMN2NPSR1
SCHEMBL11326911 0.75 FAAH (0.53) MAPTNPC1RAB9ASMN1; SMN2NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0045279-B1 AMINE OXIDE COMPOUNDS, PROCESSES FOR THEIR MANUFACTURE AND THEIR USE AS OPTICAL BRIGHTENERS CIBA-GEIGY AG (CH) 1988-06-01 — — EP claimed
EP-0029003-B1 SALTS OF CATIONIC BRIGHTENERS, THEIR PREPARATION AND THEIR USE ON ORGANIC MATERIALS AS WELL AS THEIR CONCENTRATED AQUEOUS SOLUTIONS CIBA-GEIGY AG (CH) 1984-12-05 — — EP claimed
US-4433975-A HETEROCYCLIC QUATERNARY AMMONIUM PHOSPHATES CIBA-GEIGY CORPORATION (US) 1984-02-28 — — US claimed
US-4432886-A 2-FURANYLBENZIMIDAZOLE, OR 2-AZOLYLBENZIMIDAZOLE, OR 2-STILBENYLBENZIMIDAZOLE, OR 2,5-(BENZIMIDAZOLYL)FURAN PHOSPHATES CIBA-GEIGY CORPORATION (US) 1984-02-21 — — US claimed
US-4384121-A WATER SOLUBLE CIBA-GEIGY CORPORATION (US) 1983-05-17 — — US claimed
EP-0045279-A1 Amine oxide compounds, processes for their manufacture and their use as optical brighteners CIBA-GEIGY AG (CH) 1982-02-03 — — EP claimed
EP-0029003-A2 Salts of cationic brighteners, their preparation and their use on organic materials as well as their concentrated aqueous solutions CIBA-GEIGY AG (CH) 1981-05-20 — — EP claimed
US-20070249840-A1 Process for the preparation of bis-benzazolyl compounds ELIU VICTOR P 2007-10-25 — — US disclosed
EP-1326850-B1 A PROCESS FOR THE PREPARATION OF BIS-BENZAZOLYL COMPOUNDS CIBA SC HOLDING AG (CH) 2005-11-16 — — EP disclosed
US-20030191320-A1 Process for the preparation of bis-benzazolyl compounds CIBA SPECIALTY CHEMICALS CORPORATION 2003-10-09 — — US disclosed
EP-1326850-A1 A PROCESS FOR THE PREPARATION OF BIS-BENZAZOLYL COMPOUNDS Ciba SC Holding AG (CH) 2003-07-16 — — EP disclosed
WO-2002032886-A1 A PROCESS FOR THE PREPARATION OF BIS-BENZAZOLYL COMPOUNDS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2002-04-25 — — WO disclosed
EP-0170091-B2 Liquid detergent compositions ALBRIGHT & WILSON (GB) 1997-11-19 — — EP disclosed
EP-0151884-A2 Liquid detergent compositions Albright & Wilson Limited (GB) 1985-08-21 — — EP disclosed
US-4515704-A LAUNDERING ALBRIGHT & WILSON LIMITED (GB) 1985-05-07 — — US disclosed
EP-0029003-B1 SALTS OF CATIONIC BRIGHTENERS, THEIR PREPARATION AND THEIR USE ON ORGANIC MATERIALS AS WELL AS THEIR CONCENTRATED AQUEOUS SOLUTIONS CIBA-GEIGY AG (CH) 1984-12-05 — — EP disclosed
EP-0086614-A1 Liquid detergent compositions Albright & Wilson Limited (GB) 1983-08-24 — — EP disclosed
EP-0045279-A1 Amine oxide compounds, processes for their manufacture and their use as optical brighteners CIBA-GEIGY AG (CH) 1982-02-03 — — EP disclosed
US-4295850-A Commercial preparations of dry organic substances CIBA-GEIGY CORPORATION (US) 1981-10-20 — — US disclosed
EP-0029003-A2 Salts of cationic brighteners, their preparation and their use on organic materials as well as their concentrated aqueous solutions CIBA-GEIGY AG (CH) 1981-05-20 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030191320-A1 Process for the preparation of bis-benzazolyl compounds HBZ, HBG1, OR10J3 MAPT 4632/4885NPC1 3706/4885RAB9A 2792/4885
US-20070249840-A1 Process for the preparation of bis-benzazolyl compounds HBZ, H1-3, HBS1L MAPT 4313/4885NPC1 3829/4885RAB9A 2925/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback